Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Breast Cancer
100%
PIK3CA mutation
100%
Compound mutation
100%
Extracellular Vesicles
100%
PIK3CA
100%
Non-invasive Detection
100%
Liquid Biopsy
54%
Diagnostic Technology
27%
Cancer Cells
18%
PI3K Inhibitor
18%
Alpelisib
18%
Long Distance
18%
In Cis
18%
Genetic Testing
9%
Biopsy Techniques
9%
Human Epidermal Growth Factor Receptor 2 (HER2)
9%
Breast Tumor
9%
Bloodstream
9%
Surgical Procedures
9%
Ultrasensitive
9%
Cancer Genomics
9%
Genomic DNA (gDNA)
9%
Breast Cancer Subtypes
9%
Cancer Genome
9%
Hormone Receptor
9%
Tissue Biopsy
9%
5-year Survival
9%
Hormone Receptor-positive
9%
Clinical Diagnostics
9%
Clinical Translational
9%
Pregenomic RNA (pgRNA)
9%
Noninvasive Genetic Sampling
9%
Tumor
9%
Human Epidermal Growth Factor Receptor 2-negative
9%
Lipid Nanoprobes
9%
Blood Draw
9%
Negative Breast Cancer
9%
Double mutation
9%
Breakthrough Technologies
9%
Extracellular Vesicle DNA
9%
Extracellular Vesicle Isolation
9%
Targeted Therapy
9%
Women with Breast Cancer
9%
Medicine and Dentistry
Liquid Biopsy
100%
Breast Cancer
100%
Diagnosis
66%
Malignant Neoplasm
66%
Gamma Urogastrone
33%
Biopsy Technique
33%
Epidermal Growth Factor Receptor 2
33%
Hormone Receptor
33%
Cancer Cell
33%
Genomic RNA
16%
Relative Survival
16%
Diseases
16%
Blood Flow
16%
Targeted Therapy
16%
Neoplasm
16%
Genetic Screening
16%
Cancer
16%
Genomic DNA
16%
Breast Tumor
16%
Surgical Technique
16%